Table 2.
I212N (N = 12) | I212 + HAART (N = 13) | H121N (N = 7) | H121N+HAART (N = 7) | Y955C (N = 13) | Y955C+HAART (N = 14) | WT (N = 38) | WT+HAART (N = 36) | |
---|---|---|---|---|---|---|---|---|
LVEDD (mm) | 3.52 ± 0.04 | 3.87 ± 0.07 | 3.31 ± 0.09 | 3.43 ± 0.15ns | 3.25 ± 0.08 | 3.80 ± 0.08 | 2.99 ± 0.05 | 3.15 ± 0.06 |
LVESD (mm) | 1.67 ± 0.04 | 2.07 ± 0.05 | 1.57 ± 0.08 | 1.77 ± 0.12ns | 1.63 ± 0.09 | 2.15 ± 0.10 | 1.25 ± 0.04 | 1.43 ± 0.06 |
FS (%) | 52.64 ± 0.83 | 46.44 ± 0.97 | 52.62 ± 1.64 | 48.37 ± 2.28ns | 50.01 ± 1.8 | 43.32 ± 1.6 | 58.05 ± 0.98 | 55.03 ± 1.08 |
HR (bpm) | 336 ± 31 | 358 ± 8 | 342 ± 12 | 356 ± 18 | 312 ± 8 | 273 ± 17 | 383 ± 8 | 390 ± 12 |
WT cohorts were pooled from each 2 × 2 TG and normalized. Data presented are means +/- SEM for each functional parameter. Abbreviations include: left ventricular end diastolic dimension (LVEDD), left ventricular end systolic dimension (LVESD), fractional shortening (FS), and heart rate (HR). ns = no statistical difference between vehicle treated and AZT-treated